glp 1 compounding pharmacies Compound versions of GLP-1 drugs for weight loss halted by FDA APC's Scott Brunner on GLP-1

Aims/hypothesis Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two peptides that function to promote insulin secretion

Learn about the FDA-documented link between semaglutide (Ozempic, Wegovy) and gallbladder disease, including gallstones and cholecystitis

No direct link exists, but GI side effects may trigger flares

Evaluate projects that GLP-1 obesity drugs, like Wegovy and Mounjaro, are set to drive record prescription drug sales growth by 2030.

Childhood obesity rates have skyrocketed over 300% since the 1970s, now affecting 21% of children

The patient was a 44-year-old male with severe morbid obesity, heart failure, oxygen-dependent obesity hypoventilation syndrome, uncontrolled hypertension, anemia, and depression